-
1
-
-
0029836953
-
Discovering high-affinity ligands for proteins: SAR by NMR
-
S.B. Shuker, and et al. Discovering high-affinity ligands for proteins: SAR by NMR Science 274 1996 1531 1534
-
(1996)
Science
, vol.274
, pp. 1531-1534
-
-
Shuker, S.B.1
-
3
-
-
51249121331
-
Perspectives on NMR in drug discovery: A technique comes of age
-
M. Pellecchia, and et al. Perspectives on NMR in drug discovery: a technique comes of age Nat. Rev. Drug Discov. 7 2008 738 745
-
(2008)
Nat. Rev. Drug Discov.
, vol.7
, pp. 738-745
-
-
Pellecchia, M.1
-
5
-
-
1642382166
-
Protein NMR in biomedical research
-
W. Jahnke, and H. Widmer Protein NMR in biomedical research Cell. Mol. Life Sci. 61 2004 580 599
-
(2004)
Cell. Mol. Life Sci.
, vol.61
, pp. 580-599
-
-
Jahnke, W.1
Widmer, H.2
-
6
-
-
84902125945
-
Applications of biophysics in high-throughput screening hit validation
-
C.C. Genick, and et al. Applications of biophysics in high-throughput screening hit validation J. Biomol. Screen. 19 2014 707 714
-
(2014)
J. Biomol. Screen.
, vol.19
, pp. 707-714
-
-
Genick, C.C.1
-
7
-
-
84874340334
-
Monitoring binding of HIV-1 capsid assembly inhibitors using 19F ligand- and 15N protein-based NMR and X-ray crystallography: Early hit validation of a benzodiazepine series
-
N. Goudreau, and et al. Monitoring binding of HIV-1 capsid assembly inhibitors using 19F ligand- and 15N protein-based NMR and X-ray crystallography: early hit validation of a benzodiazepine series ChemMedChem 8 2013 405 414
-
(2013)
ChemMedChem
, vol.8
, pp. 405-414
-
-
Goudreau, N.1
-
8
-
-
84891494439
-
Identification of novel drug scaffolds for inhibition of SARS-CoV 3-chymotrypsin-like protease using virtual and high-throughput screenings
-
H. Lee, and et al. Identification of novel drug scaffolds for inhibition of SARS-CoV 3-chymotrypsin-like protease using virtual and high-throughput screenings Bioorg. Med. Chem. 22 2014 167 177
-
(2014)
Bioorg. Med. Chem.
, vol.22
, pp. 167-177
-
-
Lee, H.1
-
9
-
-
24744466588
-
NMR in pharmacokinetic and pharmacodynamic profiling
-
C. Sun, and et al. NMR in pharmacokinetic and pharmacodynamic profiling ChemBioChem 6 2005 1592 1600
-
(2005)
ChemBioChem
, vol.6
, pp. 1592-1600
-
-
Sun, C.1
-
10
-
-
11844253252
-
ALARM NMR: A rapid and robust experimental method to detect reactive false positives in biochemical screens
-
J.R. Huth, and et al. ALARM NMR: a rapid and robust experimental method to detect reactive false positives in biochemical screens J. Am. Chem. Soc. 127 2005 217 224
-
(2005)
J. Am. Chem. Soc.
, vol.127
, pp. 217-224
-
-
Huth, J.R.1
-
11
-
-
84884244385
-
Monitoring drug self-aggregation and potential for promiscuity in off-target in vitro pharmacology screens by a practical NMR strategy
-
S.R. LaPlante, and et al. Monitoring drug self-aggregation and potential for promiscuity in off-target in vitro pharmacology screens by a practical NMR strategy J. Med. Chem. 56 2013 7073 7083
-
(2013)
J. Med. Chem.
, vol.56
, pp. 7073-7083
-
-
LaPlante, S.R.1
-
12
-
-
33748469378
-
Resonant waveguide grating biosensor for living cell sensing
-
Y. Fang, and et al. Resonant waveguide grating biosensor for living cell sensing Biophys. J. 91 2006 1925 1940
-
(2006)
Biophys. J.
, vol.91
, pp. 1925-1940
-
-
Fang, Y.1
-
13
-
-
34648815160
-
Free-solution, label-free molecular interactions studied by back-scattering interferometry
-
D.J. Bornhop, and et al. Free-solution, label-free molecular interactions studied by back-scattering interferometry Science 317 2007 1732 1736
-
(2007)
Science
, vol.317
, pp. 1732-1736
-
-
Bornhop, D.J.1
-
14
-
-
84855254333
-
Protein-binding assays in biological liquids using microscale thermophoresis
-
C.J. Wienken, and et al. Protein-binding assays in biological liquids using microscale thermophoresis Nat. Commun. 1 2010 100
-
(2010)
Nat. Commun.
, vol.1
, pp. 100
-
-
Wienken, C.J.1
-
15
-
-
84882963795
-
Recent developments in the use of differential scanning fluorometry in protein and small molecule discovery and characterization
-
A. Simeonov Recent developments in the use of differential scanning fluorometry in protein and small molecule discovery and characterization Expert Opin. Drug Discov. 8 2013 1071 1082
-
(2013)
Expert Opin. Drug Discov.
, vol.8
, pp. 1071-1082
-
-
Simeonov, A.1
-
16
-
-
77956185674
-
Affinity-based, biophysical methods to detect and analyze ligand binding to recombinant proteins: Matching high information content with high throughput
-
G.A. Holdgate, and et al. Affinity-based, biophysical methods to detect and analyze ligand binding to recombinant proteins: matching high information content with high throughput J. Struct. Biol. 172 2010 142 157
-
(2010)
J. Struct. Biol.
, vol.172
, pp. 142-157
-
-
Holdgate, G.A.1
-
17
-
-
84925559235
-
Biophysical screening for the discovery of small-molecule ligands
-
M. Williams, T. Daviter, Springer
-
A. Ciulli Biophysical screening for the discovery of small-molecule ligands M. Williams, T. Daviter, Protein-Ligand Interactions: Methods and Applications 2013 Springer. 357 388
-
(2013)
Protein-Ligand Interactions: Methods and Applications
, pp. 357-388
-
-
Ciulli, A.1
-
18
-
-
84944353739
-
Data quality in drug discovery: The role of analytical performance in ligand binding assays
-
H. Wätzig, and et al. Data quality in drug discovery: the role of analytical performance in ligand binding assays J. Comput. Aided Mol. Des. 29 2015 847 865
-
(2015)
J. Comput. Aided Mol. Des.
, vol.29
, pp. 847-865
-
-
Wätzig, H.1
-
19
-
-
84925559033
-
Biophysical methods in drug discovery from small molecule to pharmaceutical
-
M.A. Williams, T. Daviter, Humana Press
-
G.A. Holdgate, and et al. Biophysical methods in drug discovery from small molecule to pharmaceutical M.A. Williams, T. Daviter, Protein Ligands Interactions 2013 Humana Press 327 355
-
(2013)
Protein Ligands Interactions
, pp. 327-355
-
-
Holdgate, G.A.1
-
20
-
-
70349486038
-
Biophysical techniques for ligand screening and drug design
-
J. Renaud, and M. Delsuc Biophysical techniques for ligand screening and drug design Curr. Opin. Pharmacol. 9 2009 622 628
-
(2009)
Curr. Opin. Pharmacol.
, vol.9
, pp. 622-628
-
-
Renaud, J.1
Delsuc, M.2
-
21
-
-
77958601308
-
Affinity-based screening techniques: Their impact and benefit to increase the number of high quality leads
-
C. Bergsdorf, and J. Ottl Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads Expert Opin. Drug Discov. 5 2010 1095 1107
-
(2010)
Expert Opin. Drug Discov.
, vol.5
, pp. 1095-1107
-
-
Bergsdorf, C.1
Ottl, J.2
-
22
-
-
84906764097
-
The essential roles of chemistry in high-throughput screening triage
-
J.L. Dahlin, and M.A. Walters The essential roles of chemistry in high-throughput screening triage Future Med. Chem. 6 2014 1265 1290
-
(2014)
Future Med. Chem.
, vol.6
, pp. 1265-1290
-
-
Dahlin, J.L.1
Walters, M.A.2
-
23
-
-
84894572482
-
HTS followed by NMR based counterscreening. Discovery and optimization of pyrimidones as reversible and competitive inhibitors of xanthine oxidase
-
J. Evenäs, and et al. HTS followed by NMR based counterscreening. Discovery and optimization of pyrimidones as reversible and competitive inhibitors of xanthine oxidase Bioorg. Med. Chem. Lett. 24 2014 1315 1321
-
(2014)
Bioorg. Med. Chem. Lett.
, vol.24
, pp. 1315-1321
-
-
Evenäs, J.1
-
24
-
-
77950246109
-
SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1
-
M. Pacholec, and et al. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1 J. Biol. Chem. 285 2010 8340 8351
-
(2010)
J. Biol. Chem.
, vol.285
, pp. 8340-8351
-
-
Pacholec, M.1
-
26
-
-
84879748358
-
Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay
-
D. Martinez Molina, and et al. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay Science 341 2013 84 87
-
(2013)
Science
, vol.341
, pp. 84-87
-
-
Martinez Molina, D.1
-
27
-
-
79953703975
-
Fragment screening to predict druggability (ligandability) and lead discovery success
-
F.N.B. Edfeldt, and et al. Fragment screening to predict druggability (ligandability) and lead discovery success Drug Discov. Today 16 2011 284 287
-
(2011)
Drug Discov. Today
, vol.16
, pp. 284-287
-
-
Edfeldt, F.N.B.1
-
28
-
-
84881171375
-
Pharmacokinetics and the drug-target residence time concept
-
G. Dahl, and T. Åkerud Pharmacokinetics and the drug-target residence time concept Drug Discov. Today 18 2013 697 707
-
(2013)
Drug Discov. Today
, vol.18
, pp. 697-707
-
-
Dahl, G.1
Åkerud, T.2
-
29
-
-
84940501243
-
Ligand binding thermodynamics in drug discovery: Still a hot tip?
-
S. Geschwindner, and et al. Ligand binding thermodynamics in drug discovery: still a hot tip? J Med. Chem. 58 2015 6321 6335
-
(2015)
J Med. Chem.
, vol.58
, pp. 6321-6335
-
-
Geschwindner, S.1
-
30
-
-
42449089351
-
Enzyme kinetics and binding studies on inhibitors of MEK protein kinase
-
W.S. VanScyoc, and et al. Enzyme kinetics and binding studies on inhibitors of MEK protein kinase Biochemistry 47 2008 5017 5027
-
(2008)
Biochemistry
, vol.47
, pp. 5017-5027
-
-
VanScyoc, W.S.1
-
31
-
-
84893699626
-
Divergent kinetics differentiate the mechanism of action of two HDAC inhibitors
-
A.M. Kral, and et al. Divergent kinetics differentiate the mechanism of action of two HDAC inhibitors Biochemistry 53 2014 725 734
-
(2014)
Biochemistry
, vol.53
, pp. 725-734
-
-
Kral, A.M.1
-
32
-
-
37848998796
-
Discovery of a novel warhead against β-secretase through fragment-based lead generation
-
S. Geschwindner, and et al. Discovery of a novel warhead against β-secretase through fragment-based lead generation J. Med. Chem. 50 2007 5903 5911
-
(2007)
J. Med. Chem.
, vol.50
, pp. 5903-5911
-
-
Geschwindner, S.1
|